Chair : Emma Wilkinson

Aim: To facilitate appropriate and efficient use of medicines and pharmaceutical care for patients under the care of paediatric and neonatal gastroenterology.

Online Study Day

• How do I know how bad their liver is – understanding liver function NPPG Members only

Objectives:

• To support, promote and advise on delivery of best pharmaceutical care to paediatric and neonatal patients who:
  • Have inflammatory bowel disease OR
  • Have intestinal failure OR
  • Are on parenteral nutrition OR
  • Are treated under a gastroenterology team OR
  • Are treated under a hepatology team
• To maintain a network and provide a platform for paediatric pharmacy staff with an interest in paediatric and neonatal gastroenterology to enhance management of children’s medicines.
• To represent and champion paediatric gastroenterology pharmacy within the NPPG.
• To develop and maintain links with other national gastroenterology groups.
• To develop educational resources and signpost to resources developed by other providers.
• To assist NPPG committee responses to national consultations.
• To encourage research in the area of paediatric and neonatal gastroenterology

Scope:

• Paediatric Inflammatory Bowel Disease
• Paediatric Gastroenterology
• Paediatric PN
• Neonatal PN (for babies in DGH, term babies, surgical babies, babies on PICU)
• Paediatric Hepatology

Activities:

• Meetings: Steering group meeting quarterly.
• Online forum on NPPG message board to be created. – click here (members only)
• Study days: 1 full day study day twice a year OR ½ day study day 4 times per year. Topics may include:
  • Paediatric inflammatory bowel disease
  • Paediatric gastroenterology
  • Paediatric and neonatal PN